NCT05741905View on ClinicalTrials.gov

Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Levofloxacin

Levofloxacin is a quinolone antibiotics and newly identified neuro-protective agent. Intravenous thrombolysis is one of the treatments for acute ischemic stroke.

DRUG

Levofloxacin simulant

Levofloxacin simulant is placebo. Intravenous thrombolysis is one of the treatments for acute ischemic stroke.

Trial Locations (1)

130000

RECRUITING

First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Yi Yang

OTHER